---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-21-002832"
form_type: "8-K"
ticker: "CNBX"
cik: "0001343009"
company_name: "CNBX Pharmaceuticals Inc."
filed_at: "2021-07-06T23:59:59+00:00"
generated_at: "2026-06-30T07:11:27.972887+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Dr. Inbar Maymon Pomeranchik appointed as independent board member of Cannabics Pharmaceuticals

## Summary
- Dr. Inbar Maymon-Pomeranchik, 43, appointed to board effective July 1, 2021.
- Holds a PhD in molecular biology from Hebrew University, postdoc from Weizmann Institute, with 20 years exec experience in biotech and global medical cannabis.
- Currently serves as founder & CEO of AgChimedes Group, founder of BioDiligence, Executive Director of Ananda Developments, Director of NRGene, and Advisory Board member of Avida Global.
- Appointment was unanimously approved by the Board of Directors on July 1, 2021.

## SEC filing metadata
- accession: 0001683168-21-002832
- form_type: 8-K
- ticker: CNBX
- cik: 0001343009
- company_name: CNBX Pharmaceuticals Inc.
- filed_at: 2021-07-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1343009/000168316821002832/0001683168-21-002832-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1343009/000168316821002832/cannabics_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-21-002832
- JSON: https://secwatch.observer/filing/0001683168-21-002832.json
- Plain text: https://secwatch.observer/filing/0001683168-21-002832.txt

## Key facts
- Executive change
  Inbar Maymon Pomeranchik was appointed as Independent Board Member at CNBX Pharmaceuticals Inc..
  - Action: appointed
  - Role: Independent Board Member
  source text: On July 1 st , 2021, the Board of Directors appointed Dr. Inbar Maymon Pomeranchik as an Independent Board Member.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1343009/000168316821002832/0001683168-21-002832-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.